Müller-Ladner U, Pap T, Gay RE, Neidhart M, Gay S: Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol. 2005, 1: 102-110. 10.1038/ncprheum0047.
Article
PubMed
Google Scholar
Smolen JS, Steiner G: Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov. 2003, 2: 473-488. 10.1038/nrd1109.
Article
CAS
PubMed
Google Scholar
Smolen J, Aletaha D: The burden of rheumatoid arthritis and access to treatment: a medical overview. Eur J Health Econ. 2008, 8: S39-47. 10.1007/s10198-007-0087-9.
Article
PubMed
Google Scholar
Luyten FP, Lories RJ, Verschueren P, de Vlam K, Westhovens R: Contemporary concepts of inflammation, damage and repair in rheumatic diseases. Best Pract Res Clin Rheumatol. 2006, 20: 829-848. 10.1016/j.berh.2006.06.009.
Article
CAS
PubMed
Google Scholar
Häupl T, Krenn V, Stuhlmüller B, Radbruch A, Burmester GR: Perspectives and limitations of gene expression profiling in rheumatology: new molecular strategies. Arthritis Res Ther. 2004, 6: 140-146. 10.1186/ar1194.
Article
PubMed Central
PubMed
Google Scholar
Karouzakis E, Neidhart M, Gay RE, Gay S: Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett. 2006, 106: 8-13. 10.1016/j.imlet.2006.04.011.
Article
CAS
PubMed
Google Scholar
Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T: Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford). 2006, 45: 669-675. 10.1093/rheumatology/kel065.
Article
CAS
Google Scholar
Ruschpler P, Lorenz P, Eichler W, Koczan D, Hanel C, Scholz R, Melzer C, Thiesen HJ, Stiehl P: High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res Ther. 2003, 5: R241-252. 10.1186/ar783.
Article
PubMed Central
CAS
PubMed
Google Scholar
Devauchelle V, Marion S, Cagnard N, Mistou S, Falgarone G, Breban M, Letourneur F, Pitaval A, Alibert O, Lucchesi C, Anract P, Hamadouche M, Ayral X, Dougados M, Gidrol X, Fournier C, Chiocchia G: DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. Genes Immun. 2004, 5: 597-608. 10.1038/sj.gene.6364132.
Article
CAS
PubMed
Google Scholar
Justen HP, Grunewald E, Totzke G, Gouni-Berthold I, Sachinidis A, Wessinghage D, Vetter H, Schulze-Osthoff K, Ko Y: Differential gene expression in synovium of rheumatoid arthritis and osteoarthritis. Mol Cell Biol Res Commun. 2000, 3: 165-172. 10.1006/mcbr.2000.0211.
Article
CAS
PubMed
Google Scholar
Mastbergen SC, Lafeber FP, Bijlsma JW: Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage. Rheumatology (Oxford). 2002, 41: 801-808. 10.1093/rheumatology/41.7.801.
Article
CAS
Google Scholar
Tak PP: Chemokine inhibition in inflammatory arthritis. Best Pract Res Clin Rheumatol. 2006, 20: 929-939. 10.1016/j.berh.2006.06.001.
Article
CAS
PubMed
Google Scholar
Connell L, McInnes IB: New cytokine targets in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol. 2006, 20: 865-878. 10.1016/j.berh.2006.05.011.
Article
CAS
PubMed
Google Scholar
Häupl T, Yahyawi M, Lübke C, Ringe J, Rohrlach T, Burmester GR, Sittinger M, Kaps C: Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen. 2007, 12: 328-340. 10.1177/1087057107299261.
Article
PubMed
Google Scholar
Goldring SR: Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford). 2003, 42: ii11-16. 10.1093/rheumatology/keg327.
Article
CAS
Google Scholar
Burrage PS, Mix KS, Brinckerhoff CE: Matrix metalloproteinases: role in arthritis. Front Biosci. 2006, 11: 529-543. 10.2741/1817.
Article
CAS
PubMed
Google Scholar
Goldring MB, Berenbaum F: The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res. 2004, S37-46. 10.1097/01.blo.0000144484.69656.e4. 427 Suppl
Andreas K, Lübke C, Häupl T, Dehne T, Morawietz L, Ringe J, Kaps C, Sittinger M: Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study. Arthritis Res Ther. 2008, 10: R9-10.1186/ar2358.
Article
PubMed Central
PubMed
Google Scholar
Kaps C, Frauenschuh S, Endres M, Ringe J, Haisch A, Lauber J, Buer J, Krenn V, Häupl T, Burmester GR, Sittinger M: Gene expression profiling of human articular cartilage grafts generated by tissue engineering. Biomaterials. 2006, 27: 3617-3630.
CAS
PubMed
Google Scholar
Aicher WK, Dinkel A, Grimbacher B, Haas C, Seydlitz-Kurzbach EV, Peter HH, Eibel H: Serum response elements activate and cAMP responsive elements inhibit expression of transcription factor Egr-1 in synovial fibroblasts of rheumatoid arthritis patients. Int Immunol. 1999, 11: 47-61. 10.1093/intimm/11.1.47.
Article
CAS
PubMed
Google Scholar
Parak WJ, Dannohl S, George M, Schuler MK, Schaumburger J, Gaub HE, Muller O, Aicher WK: Metabolic activation stimulates acid production in synovial fibroblasts. J Rheumatol. 2000, 27: 2312-2322.
CAS
PubMed
Google Scholar
Haas C, Aicher WK, Dinkel A, Peter HH, Eibel H: Characterization of SV40T antigen immortalized human synovial fibroblasts: maintained expression patterns of EGR-1, HLA-DR and some surface receptors. Rheumatol Int. 1997, 16: 241-247. 10.1007/BF01375656.
Article
CAS
PubMed
Google Scholar
Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31: e15-10.1093/nar/gng015.
Article
PubMed Central
PubMed
Google Scholar
Sturn A, Quackenbush J, Trajanoski Z: Genesis: cluster analysis of microarray data. Bioinformatics. 2002, 18: 207-208. 10.1093/bioinformatics/18.1.207.
Article
CAS
PubMed
Google Scholar
Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y: KEGG for linking genomes to life and the environment. Nucleic Acids Res. 2008, 36: D480-484. 10.1093/nar/gkm882.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28: 27-30. 10.1093/nar/28.1.27.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kanbe K, Takagishi K, Chen Q: Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum. 2002, 46: 130-137. 10.1002/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D.
Article
CAS
PubMed
Google Scholar
Wei L, Sun X, Kanbe K, Wang Z, Sun C, Terek R, Chen Q: Chondrocyte death induced by pathological concentration of chemokine stromal cell-derived factor-1. J Rheumatol. 2006, 33: 1818-1826.
CAS
PubMed
Google Scholar
Eerden Van Der BC, Ven Van der J, Lowik CW, Wit JM, Karperien M: Sex steroid metabolism in the tibial growth plate of the rat. Endocrinology. 2002, 143: 4048-4055. 10.1210/en.2002-220093.
Article
Google Scholar
Maeda A, Nishida T, Aoyama E, Kubota S, Lyons KM, Kuboki T, Takigawa M: CCN family 2/connective tissue growth factor modulates BMP signaling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes. J Biochem. 2009, 145: 207-216. 10.1093/jb/mvn159.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wong M, Kireeva ML, Kolesnikova TV, Lau LF: Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. Dev Biol. 1997, 192: 492-508. 10.1006/dbio.1997.8766.
Article
CAS
PubMed
Google Scholar
Laan RF, Jansen TL, van Riel PL: Glucocorticosteroids in the management of rheumatoid arthritis. Rheumatology (Oxford). 1999, 38: 6-12. 10.1093/rheumatology/38.1.6.
Article
CAS
Google Scholar
Bijlsma JW, Boers M, Saag KG, Furst DE: Glucocorticoids in the treatment of early and late RA. Ann Rheum Dis. 2003, 62: 1033-1037. 10.1136/ard.62.11.1033.
Article
PubMed Central
CAS
PubMed
Google Scholar
Doan T, Massarotti E: Rheumatoid arthritis: an overview of new and emerging therapies. J Clin Pharmacol. 2005, 45: 751-762. 10.1177/0091270005277938.
Article
CAS
PubMed
Google Scholar
Kirwan JR: The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med. 1995, 333: 142-146. 10.1056/NEJM199507203330302.
Article
CAS
PubMed
Google Scholar
Skoumal M, Haberhauer G, Feyertag J, Kittl EM, Bauer K, Dunky A: Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment. Rheumatol Int. 2006, 26: 1001-1004. 10.1007/s00296-006-0117-4.
Article
CAS
PubMed
Google Scholar
Weinblatt ME: Rheumatoid arthritis in 2003: where are we now with treatment?. Ann Rheum Dis. 2003, 62: ii94-96. 10.1136/ard.62.suppl_2.ii94.
Article
PubMed Central
PubMed
Google Scholar
Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen JS: Methotrexate as the 'anchor drug' for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol. 2003, 21: S179-S185.
CAS
PubMed
Google Scholar
Sahasranaman S, Howard D, Roy S: Clinical pharmacology and pharmacogenetics of thiopurines. Eur J Clin Pharmacol. 2008, 64: 753-767. 10.1007/s00228-008-0478-6.
Article
CAS
PubMed
Google Scholar
Stuhlmeier KM: The anti-rheumatic gold salt aurothiomalate suppresses interleukin-1beta-induced hyaluronan accumulation by blocking HAS1 transcription and by acting as a COX-2 transcriptional repressor. J Biol Chem. 2007, 282: 2250-2258. 10.1074/jbc.M605011200.
Article
CAS
PubMed
Google Scholar
Nieminen R, Vuolteenaho K, Riutta A, Krankaanranta H, Kraan van der PM, Moilanen T, Moilanen E: Aurothiomalate inhibits COX-2 expression in chondrocytes and in human cartilage possibly through its effects on COX-2 mRNA stability. Eur J Pharmacol. 2008, 587: 309-316. 10.1016/j.ejphar.2008.03.016.
Article
CAS
PubMed
Google Scholar
Sanders M: A review of controlled clinical trials examining the effects of antimalarial compounds and gold compounds on radiographic progression in rheumatoid arthritis. J Rheumatol. 2000, 27: 523-529.
CAS
PubMed
Google Scholar
Berg van den WB: Impact of NSAID and steroids on cartilage destruction in murine antigen induced arthritis. J Rheumatol Suppl. 1991, 27: 122-123.
PubMed
Google Scholar
López-Armada MJ, Sánchez-Pernaute O, Largo R, Diez-Ortego I, Palacios I, Egido J, Herrero-Beaumont G: Modulation of cell recruitment by anti-inflammatory agents in antigen-induced arthritis. Ann Rheum Dis. 2002, 61: 1027-1030. 10.1136/ard.61.11.1027.
Article
PubMed Central
PubMed
Google Scholar
Chizzolini C, Chicheportiche R, Alvarez M, de Rham C, Roux-Lombard P, Ferrari-Lacraz S, Dayer JM: Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood. 2008, 112: 3696-3703. 10.1182/blood-2008-05-155408.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D: Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J. 2004, 18: 1318-1320.
CAS
PubMed
Google Scholar
Ogura H, Murakami M, Okuyama Y, Tsuruoka M, Kitabayashi C, Kanamoto M, Nishihara M, Iwakura Y, Hirano T: Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity. 2008, 29: 628-636. 10.1016/j.immuni.2008.07.018.
Article
CAS
PubMed
Google Scholar
Bork P: The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 1993, 327: 125-130. 10.1016/0014-5793(93)80155-N.
Article
CAS
PubMed
Google Scholar
Sato S, Nagaoka T, Hasegawa M, Tamatani T, Nakanishi T, Takigawa M, Takehara K: Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol. 2000, 27: 149-154.
CAS
PubMed
Google Scholar
Cheng O, Thuillier R, Sampson E, Schultz G, Ruiz P, Zhang X, Yuen PS, Mannon RB: Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant. 2006, 6: 2292-2306. 10.1111/j.1600-6143.2006.01493.x.
Article
CAS
PubMed
Google Scholar